Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.265 AUD -0.01 ( 3.64%)
Last update at 2026-11-06T04:36:00Z
VOLUME
69260
Market Cap
103.06M
P/E
13.75

Momentum Score

…

Austco Healthcare Limited, together with its subsidiaries, engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call system; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; clinical workflow that allows healthcare staff to communicate with ancillary departments, measure adherence to protocol, and control other systems; Built-in RTLS, a nurse call platform; enterprise reporting; and integration services. It is also involved in the marketing, sales, and installation of electronic healthcare communication systems; and development of software and manufacture of hardware relating to healthcare and electronic communications systems. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.27
Low
0.28
High
52 Week Price Range
0.19
Low
0.45
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Austco Healthcare Ltd supplies clinical communication, nurse-call systems and software to hospitals and aged-care providers in Australia and select overseas markets. Long-term growth may be supported by ageing populations, healthcare digitisation, regulatory focus on residential care and periodic technology upgrades, and the company appears positioned to capture recurring service and upgrade demand.

Major risks include dependence on aged-care and public procurement cycles, competition from larger vendors, execution risk on rollouts and exposure to supply-chain, currency and healthcare budget pressures that investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.28
Dividend Yield
-
Revenue TTM
94.24M
Revenue Per Share
0.25
Gross Profit TTM
50.29M
Debt / Equity
0.06
ROE
15.82%
Net Debt
-12.33M
ROCE
16.66%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 11.58M 8.06M 5.65M 1.81M 2.63M
Minority interest 0.00M - - - -
Net income 9.01M 5.93M 7.08M 2.26M 2.33M
Selling general administrative 26.16M 1.46M 1.46M 14.42M 11.98M
Selling and marketing expenses - 25.62M 19.14M -12.74M -
Gross profit 20.96M 42.37M 30.67M 6.68M 18.85M
Reconciled depreciation 3.97M 2.87M 2.31M 1.72M 1.38M
Ebit 10.82M 10.59M 5.80M 1.80M 2.14M
Ebitda 14.80M 11.10M 8.11M 3.52M 3.52M
Depreciation and amortization 3.97M 0.51M 2.31M 1.72M 1.38M
Operating income 10.82M 10.87M 5.79M 1.80M 2.14M
Other operating expenses 83.42M 70.53M 52.37M 40.17M 33.74M
Interest expense 0.39M 0.23M 0.15M 0.07M 0.05M
Tax provision 2.58M 2.12M -1.43M -0.44M 0.30M
Interest income 0.17M 0.32M 0.06M 0.04M 0.02M
Net interest income -0.21M 0.10M -0.09M -0.03M -0.03M
Income tax expense 2.58M 2.12M -1.43M -0.44M 0.30M
Total revenue 94.24M 81.41M 58.15M 41.98M 35.88M
Total operating expenses 10.14M 31.50M 24.89M 4.88M 16.71M
Cost of revenue 73.28M 39.03M 27.48M 35.29M 17.03M
Total other income expense net 0.76M -2.82M -0.14M 0.01M 0.52M
Net income from continuing ops 9.00M 5.93M 7.08M 2.26M 2.33M
Net income applicable to common shares - 5.93M 7.08M 2.26M 2.33M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 88.50M 91.07M 68.72M 37.81M 34.03M
Intangible assets 6.84M 6.79M - 5.46M 4.68M
Other current assets 2.39M 4.18M 1.81M 0.22M 1.54M
Total liab 26.38M 39.34M 24.34M 12.81M 10.94M
Total stockholder equity 62.12M 51.73M 44.38M 25.00M 23.09M
Deferred long term liab - - - 5.46M 4.68M
Other current liab 6.57M 9.39M 4.49M 2.57M 3.50M
Common stock 58.48M - 54.47M 42.19M 41.72M
Capital stock 58.48M 54.89M - 42.19M 41.72M
Retained earnings 4.57M -4.44M -10.63M -17.86M -18.90M
Other liab - - - 0.05M 0.04M
Good will 21.35M 21.35M 14.49M - -
Other assets - - 0.00M 7.18M 5.60M
Cash 16.28M 14.48M 13.56M 4.67M 7.63M
Cash and equivalents - - - 4.67M 7.63M
Total current liabilities 23.54M 33.15M 17.06M 12.64M 10.49M
Current deferred revenue 3.80M - 2.67M - 1.44M
Net debt -12.33M - -11.78M - -6.65M
Short term debt 1.24M - 0.57M 0.02M 0.56M
Short long term debt 0.14M 0.16M - 0.02M 0.05M
Short long term debt total 3.95M - 1.78M - 0.98M
Other stockholder equity 0.00M - - 0.67M 0.27M
Property plant equipment - - - 0.85M 1.09M
Total current assets 50.31M 51.55M 40.57M 29.79M 27.34M
Net tangible assets - - - 25.00M 23.09M
Net receivables 20.35M 21.82M 14.53M 12.83M 7.62M
Inventory 11.30M 9.28M 10.67M 10.83M 9.21M
Accounts payable 11.94M 10.97M 9.32M 8.34M 6.74M
Accumulated other comprehensive income -0.93M - 0.54M - 0.27M
Non currrent assets other - - 6.26M - -
Non current assets total 38.18M 39.51M 28.15M 8.02M 6.70M
Capital lease obligations 3.81M 3.72M - 0.50M 0.93M
Long term debt total - - - 0.12M 0.42M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -12.32M -11.06M -1.57M -1.63M
Change to liabilities - - - 1.79M 3.13M
Total cashflows from investing activities -8.82M -12.32M -11.06M -1.57M -1.63M
Net borrowings - - -0.01M -0.69M -0.60M
Total cash from financing activities -1.43M -0.40M 8.84M -1.58M -0.31M
Change to operating activities - - - 0.80M -0.10M
Net income 9.01M 5.93M 7.08M 2.26M 2.33M
Change in cash 1.79M 0.93M 8.88M -2.96M -0.14M
Begin period cash flow 14.48M 13.56M 4.67M 7.63M 7.77M
End period cash flow 16.28M 14.48M 13.56M 4.67M 7.63M
Total cash from operating activities 12.51M 13.42M 11.35M 0.32M 1.94M
Issuance of capital stock - 0.42M 9.58M - 0.28M
Depreciation 3.97M 2.87M 2.31M 1.72M 1.38M
Other cashflows from investing activities -6.04M -2.77M -2.27M - -
Dividends paid - - 0.00M -0.90M 0.90M
Change to inventory -2.02M 1.39M 0.16M -1.61M -3.53M
Change to account receivables 3.51M -8.58M -0.91M -4.60M -1.57M
Sale purchase of stock -0.02M 0.42M 9.58M 0.00M 0.28M
Other cashflows from financing activities -1.43M - -0.73M -0.66M -0.57M
Change to netincome - - - 0.21M 0.44M
Capital expenditures 0.79M 2.76M 3.90M 1.57M 1.63M
Change in working capital -2.23M -3.49M 1.62M -3.87M -2.04M
Stock based compensation - 0.31M 0.19M 0.15M 0.19M
Other non cash items 1.76M 7.80M 0.15M 7.26M 0.25M
Free cash flow 11.72M 10.66M 7.45M -1.25M 0.32M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AHC
Austco Healthcare Ltd
-0.01
3.64%
0.27 13.75 16.31 1.09 1.63 0.94 5.71
RMD
Resmed Inc
0.14
0.40%
34.75 21.77 19.57 8.49 5.53 5.50 14.10
FPH
Fisher & Paykel Healthcare Corporation Ltd
0.31
0.80%
39.20 55.56 48.54 9.91 12.92 11.78 33.96
ANN
Ansell Ltd
0.14
0.31%
45.66 21.27 22.73 2.99 2.16 2.24 12.03
NAN
Nanosonics Ltd
-0.06
2.03%
2.89 49.17 78.12 4.33 4.02 3.64 24.30

Profile*

Austco Healthcare Ltd

Austco Healthcare Limited, together with its subsidiaries, engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call system; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; clinical workflow that allows healthcare staff to communicate with ancillary departments, measure adherence to protocol, and control other systems; Built-in RTLS, a nurse call platform; enterprise reporting; and integration services. It is also involved in the marketing, sales, and installation of electronic healthcare communication systems; and development of software and manufacture of hardware relating to healthcare and electronic communications systems. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.

484 Graham Street, Port Melbourne, VIC, Australia, 3207

61 3 9209 9688

Name Title Year Born
Mr. Clayton Astles CEO, MD & Exec. Director NA
Mr. Brendan James Maher CFO & Company Sec. 1968
Mr. Andrew Hall Chief Commercial Officer NA
Mr. Michael Read Gen. Mang. of Australasia NA
Mr. Clayton Astles CEO, MD & Executive Director NA
Mr. Brendan James Maher CFO & Company Secretary 1968
Mr. Clayton Astles CEO, MD & Executive Director NA
Mr. Brendan James Maher CFO & Company Secretary 1968
Mr. Clayton Astles CEO, MD & Executive Director NA
Mr. Brendan James Maher CFO & Company Secretary 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…